SARS-CoV-2 Mpro-IN-21
SARS-CoV-2 Mpro-IN-21 (compound A8) is a potent SARS-CoV-2 and OVID-19 Main Protease MPro inhibitor. SARS-CoV-2 Mpro-IN-21 shows excellent antioxidant activity in DPPH assay with an IC50 of 0.36 mg/mL. SARS-CoV-2 Mpro-IN-21 also exhibits better antibacterial potency against Klebsiella with an IC50 of 1.19 mg/mL[1].
Product Specifications
CAS Number
[3041099-79-7]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-mpro-in-21.html
Smiles
O=C(N(CC)C(N1CC)=S)/C(C1=O)=C/NCCC2=CC=CC=C2
Molecular Formula
C17H21N3O2S
Molecular Weight
331.43
References & Citations
[1]Sarfraz M, et al. New Pyrimidinone Bearing Aminomethylenes and Schiff Bases as Potent Antioxidant, Antibacterial, SARS-CoV-2, and COVID-19 Main Protease MPro Inhibitors: Design, Synthesis, Bioactivities, and Computational Studies. ACS Omega. 2024 Jun 4;9 (24) :25730-25747.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6282560-01 0.1 mL
CCNY, ID (CCNY, C10orf9, CBCP1, CFP1, Cyclin-Y, Cyclin box protein 1, Cyclin fold protein 1, cyclin-X) (MaxLight 550)
Ask
View Details MBS6282560-02 5x 0.1 mL
CCNY, ID (CCNY, C10orf9, CBCP1, CFP1, Cyclin-Y, Cyclin box protein 1, Cyclin fold protein 1, cyclin-X) (MaxLight 550)
Ask
View Details 